Information
The accreditation of this program was recognized by CCCEP under the file number #1614-2021-3208-I-P ONTARGET until May 27th, 2024. It is no longer possible to obtain credits further to reading the existing chapters.
The OnTarget team is currently developing a new format of continuing education. We will inform you once this or these new programs are available.
In the interim, we will continue to update the resource with new classes and molecules.
For any questions or suggestions of new continuing education topics, do not hesitate to reach out via the “Contact” page found on the home page of the website.
Program Learning Objectives
From now until the launch of the next educational program, the learning objectives of the expired content remain valuable for daily consulting of the website (without credits).
Upon reading the chapters of the OnTarget website, pharmacists will be able to:
- Identify the key molecular targets of medications used for the treatment of cancer.
- Identify the common adverse events of targeted cancer therapies, based on their specific target and the common adverse events of individual therapies.
- Assess symptoms and apply the most appropriate management strategies to minimize impact on the patient's quality of life.
- Educate and inform your patients about potential common adverse events.
- Make appropriate referrals to oncologists or other healthcare professionals, when required.